| Mepha Pharma AG - Rivaroxaban-Amlodipin-Mepha 15 mg/5 mg, Tabletten | | 69789 | | 01 | | Rivaroxaban-Amlodipin-Mepha 15 mg/5 mg | | Tabletten | | B01AF | | Direct Factor Xa Inhibitors | | 26.09.2025 | | |
| | Composition | | rivaroxabanum 15 mg, amlodipinum 5 mg ut amlodipini besilas 6.93 mg, mannitolum, cellulosum microcristallinum, carmellosum natricum conexum, natrii laurilsulfas, hypromellosum, calcii hydrogenophosphas, E 172 (rubrum), silica colloidalis anhydrica, magnesii stearas, pro compresso corresp. natrium 1.2 mg. | | Packungsbestandteile | | Comprimés | | | | Principe actif | Concentr. |
|---|
| Amlodipine | 5 mg | | Rivaroxabanum | 15 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| (Rubrum) | | | | Calcium Hydrogenophosphate | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 172 | | color. | | Hypromellosum | | | | Magnesii Stearas | | | | Mannitol | | | | Natrii Laurilsulfas | | | | Pro Compresso | | | | Silica Colloidalis Anhydrica | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 30 | | | B | | Oui | | 002 | 90 | | | B | | Oui |
|
|
